PL2046830T3 - Polipeptydy CSF3R i ich zastosowania - Google Patents
Polipeptydy CSF3R i ich zastosowaniaInfo
- Publication number
- PL2046830T3 PL2046830T3 PL07787134T PL07787134T PL2046830T3 PL 2046830 T3 PL2046830 T3 PL 2046830T3 PL 07787134 T PL07787134 T PL 07787134T PL 07787134 T PL07787134 T PL 07787134T PL 2046830 T3 PL2046830 T3 PL 2046830T3
- Authority
- PL
- Poland
- Prior art keywords
- csf3r
- polypeptides
- csf3r polypeptides
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7153—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for colony-stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Communicable Diseases (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Transplantation (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06116704 | 2006-07-06 | ||
US83217706P | 2006-07-19 | 2006-07-19 | |
EP07787134A EP2046830B1 (en) | 2006-07-06 | 2007-07-05 | Csf3r polypeptides and uses thereof |
PCT/EP2007/056846 WO2008003763A1 (en) | 2006-07-06 | 2007-07-05 | Csf3r polypeptides and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2046830T3 true PL2046830T3 (pl) | 2011-11-30 |
Family
ID=38687985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07787134T PL2046830T3 (pl) | 2006-07-06 | 2007-07-05 | Polipeptydy CSF3R i ich zastosowania |
Country Status (9)
Country | Link |
---|---|
US (1) | US7871979B2 (pl) |
EP (1) | EP2046830B1 (pl) |
JP (1) | JP2009542197A (pl) |
AU (1) | AU2007271163B2 (pl) |
CA (1) | CA2654894A1 (pl) |
CY (1) | CY1111774T1 (pl) |
IL (1) | IL196292A0 (pl) |
PL (1) | PL2046830T3 (pl) |
WO (1) | WO2008003763A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101750426B1 (ko) * | 2009-09-15 | 2017-06-23 | 씨에스엘 리미티드 | 신경 질환들의 치료 |
CA2838246C (en) * | 2011-06-13 | 2018-07-10 | Csl Limited | Antibodies against g-csfr and uses thereof |
KR20220103718A (ko) * | 2019-10-18 | 2022-07-22 | 가부시키가이샤 바이오지프코드 | 줄기 세포 이동제를 사용한 당뇨병 치료 |
KR20230152099A (ko) * | 2021-02-26 | 2023-11-02 | 가부시키가이샤 바이오지프코드 | 당뇨병 및 합병증의 신규 치료, 진단 및 검출을 위한 방법 및 제제 |
WO2023038416A1 (ko) * | 2021-09-07 | 2023-03-16 | 주식회사 에프엔씨티바이오텍 | 폐 섬유증의 바이오마커 및 치료 표적으로서 csf3r |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7695723B2 (en) | 2002-12-31 | 2010-04-13 | Sygnis Bioscience Gmbh & Co. Kg | Methods of treating neurological conditions with hematopoietic growth factors |
-
2007
- 2007-07-05 AU AU2007271163A patent/AU2007271163B2/en not_active Expired - Fee Related
- 2007-07-05 PL PL07787134T patent/PL2046830T3/pl unknown
- 2007-07-05 EP EP07787134A patent/EP2046830B1/en not_active Not-in-force
- 2007-07-05 CA CA002654894A patent/CA2654894A1/en not_active Abandoned
- 2007-07-05 JP JP2009517279A patent/JP2009542197A/ja not_active Withdrawn
- 2007-07-05 US US12/304,427 patent/US7871979B2/en not_active Expired - Fee Related
- 2007-07-05 WO PCT/EP2007/056846 patent/WO2008003763A1/en active Application Filing
-
2008
- 2008-12-31 IL IL196292A patent/IL196292A0/en unknown
-
2011
- 2011-08-26 CY CY20111100814T patent/CY1111774T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007271163A1 (en) | 2008-01-10 |
CA2654894A1 (en) | 2008-10-01 |
US20100004167A1 (en) | 2010-01-07 |
AU2007271163B2 (en) | 2012-08-23 |
WO2008003763A1 (en) | 2008-01-10 |
US7871979B2 (en) | 2011-01-18 |
JP2009542197A (ja) | 2009-12-03 |
EP2046830B1 (en) | 2011-06-15 |
CY1111774T1 (el) | 2015-10-07 |
IL196292A0 (en) | 2011-08-01 |
EP2046830A1 (en) | 2009-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL247617A0 (en) | Peptide nanoparticles and their uses | |
IL179300A0 (en) | Novel-antigen-binding polypeptides and their uses | |
ZA200810323B (en) | Fkbp-l and uses thereof | |
IL218776A0 (en) | Modified factor vii polypeptides and uses thereof | |
EP1976864A4 (en) | NEW PEPTIDE AND ITS USE | |
HK1121470A1 (en) | Binding polypeptides and uses thereof | |
GB0524788D0 (en) | Polypeptides | |
PL2064327T3 (pl) | Dbait i ich zastosowania | |
EP2005171A4 (en) | SERUM INHIBITORY INFLAMMATORY FACTORS AND USES THEREOF | |
GB0621513D0 (en) | Novel polypeptides and uses thereof | |
GB0600927D0 (en) | Assay and materials therefor | |
GB0708376D0 (en) | Novel polypeptides and uses thereof | |
IL185308A0 (en) | Replikin peptides and uses thereof | |
HK1133552A1 (en) | Carboranylporphyrins and uses thereof | |
IL193700A0 (en) | Medicaments and proteins | |
IL195525A0 (en) | Replikin peptides and uses thereof | |
GB0607798D0 (en) | Novel polypeptides and use thereof | |
GB0616230D0 (en) | Biomarkers and uses thereof | |
GB0604187D0 (en) | Peptide and uses thereof | |
PL2046830T3 (pl) | Polipeptydy CSF3R i ich zastosowania | |
GB0505949D0 (en) | Polypeptides | |
GB0623539D0 (en) | Polypeptides | |
SI2032708T1 (sl) | Rekombinantni novirabdovirusi in njihove uporabe | |
GB0600336D0 (en) | Composition and uses thereof | |
GB0516571D0 (en) | Novel polypeptides and uses thereof |